Hereditary Angioedema Attacks: Local Swelling at Multiple Sites

Clinical Reviews in Allergy and Immunology

Volumn 50, Issue 1, 2016, Pages 34-40

  Hofman, Zonne L M ^a   Relan, Anurag ^b   Hack, C Erik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Pharming Group NV   (Netherlands)

Author keywords

C1 inhibitor deficiency; Hereditary angioedema

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C4; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C1S INHIBITOR; RECOMBINANT PROTEIN;

ABDOMINAL SWELLING; ADULT; AGE DISTRIBUTION; ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE DURATION; DISEASE SEVERITY; DYSPHAGIA; DYSPNEA; FEMALE; HUMAN; LARYNX DISORDER; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; SEX DIFFERENCE; UROGENITAL TRACT DISEASE; VISUAL ANALOG SCALE; VOICE CHANGE; ADOLESCENT; AGED; ANGIOEDEMAS, HEREDITARY; DISEASE COURSE; MIDDLE AGED; PATHOLOGY; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANGIOEDEMAS, HEREDITARY; BIOMARKERS; C-REACTIVE PROTEIN; COMPLEMENT C1 INHIBITOR PROTEIN; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREMEDICATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84957426668     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-014-8463-6     Document Type: Article

References (25)

1. Osler W (1888) Hereditary angio-neurotic oedema. Am J Med Sci 95:362–367
2. Donaldson VH, Evans RR (1963) A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C1-esterase. Am J Med 31:37–44
3. Bork K, Meng G, Staubach P, Hardt J (2006) Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 119:267–274
4. Agostoni A, Aygören-Pürsün E, Binkley K et al (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51–S131
5. Nzeako UC, Frigas E, Tremaine WJ (2001) Hereditary angioedema: a broad review for clinicians. Arch Intern Med 161:2417–2429
6. Caballero T, Aygören-Pürsün E, Bygum A et al (2013) The humanistic burden of hereditary angioedema: results from the burden of illness study in Europe. Allergy Asthma Proc. doi:10.2500/ aap.2013.34.3685, Advance online publication
7. Cicardi M, Bergamaschini L, Marasini B, Boccassini G, Tucci A, Agostoni A (1982) Hereditary angioedema: an appraisal of 104 cases. Am J Med Sci 284:2–9
8. Kusuma A, Relan A, Knulst AC et al (2012) Clinical impact of peripheral attacks in hereditary angioedema patients. Am J Med 125:937.e17-24
9. Rubinstein E, Stolz LE, Sheffer AL, Stevens C, Bousvaros A (2014) Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC Gastroenterol 14:71
10. Vernon MK, Rentz AM, Wyrwich KW, White MV, Grienenberger A (2009) Psychometric validation of two patient-reported outcome measures to assess symptoms severity and changes in symptoms in hereditary angioedema. Qual Life Res 18:929–939
11. Choi G, Soeters MR, Farkas H et al (2007) Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Transfusion 47:1028–1032
12. Zuraw B, Cicardi M, Levy RJ et al (2010) Recombinant human C1-inhibitorfor the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol 126:821–827
13. McMillan CV, Speight J, Rela A, Bellizzi L, Haase G, Cicardi M (2012) Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study. Patient 5:113–126
14. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-oedema. Lancet 351:1693–1697
15. Zuraw BJ (2008) Hereditary angioedema. N Engl J Med 359:1027–1036
16. Pappalardo E, Caccia S, Suffritti C, Tordai A, Zingale LC, Cicardi M (2008) Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. Mol Immunol 45:3536–3544
17. Maurer M, Bader M, Bas M et al (2011) New topics in bradykinin research. Allergy 66:1397–1406
18. Nussberger J, Cugno M, Cicardi M, Agostoni A (1999) Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol 104:1321–1322
19. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27–77
20. Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE 3rd (2002) Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 109:1057–1063
21. Bossi F, Fischetti F, Regoli D et al (2009) Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol 124:1303–1310
22. Zhou X, Polgar P, Taylor L (1998) Roles for interleukin-1beta, phorbol ester and a post-transcriptional regulator in the control of bradykinin B1 receptor gene expression. Biochem J 330:361–366
23. Phagoo SB, Yaqoob M, Herrera-Martinez E, McIntyre P, Jones C, Burgess GM (2000) Regulation of bradykinin receptor gene expression in human lung fibroblasts. Eur J Pharmacol 397:237–246
24. Hofman ZLM, Relan A, Hack CE (2014) C-reactive protein in hereditary angioedema. Clin Exp Immunol 177:280–286
25. Arcoleo F, Salemi ML, Porta A et al (2014) Upregulation of cytokines and IL-17 in patients with hereditary angioedema. Clin Chem Lab Med 52:e91–e93